Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy

Biomaterials

Volumn 34, Issue 2, 2013, Pages 552-561

  Lee, Seung Young ^a   Kim, Sungwon ^b   Tyler, Jacqueline Y ^a   Park, Kinam ^a,b   Cheng, Ji Xin ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Confocal microscopy; Controlled drug release; Cross linking; In vivo test; Micelle; Molecular imaging

Indexed keywords

CANCER CELLS; CANCER CHEMOTHERAPY; CONTROLLED DRUG RELEASE; DOXORUBICIN; DRUG CARRIER; DRUG RELEASE; IN-VIVO; IN-VIVO TESTS; NANOCARRIERS; SELF-ASSEMBLED; SYSTEMIC ADMINISTRATION; TARGETED DELIVERY; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

BLOOD; CHEMOTHERAPY; CONFOCAL MICROSCOPY; MOLECULAR IMAGING; MOTION PICTURE EXPERTS GROUP STANDARDS; SULFUR COMPOUNDS; TUMORS;

MICELLES;

DISULFIDE; DOXORUBICIN; DRUG CARRIER; METHOXYPOLY(ETHYLENE GLYCOL) (CYSTEINE) 4 POLY(DEXTRO,LEVO LACTIC ACID); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISULFIDE BOND; DRUG BLOOD LEVEL; MALE; MICELLE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CYSTEINE; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; LACTIC ACID; MALE; MICE; MICE, INBRED BALB C; MICELLES; NEOPLASMS; POLYETHYLENE GLYCOLS; POLYMERS;

MUS;

EID: 84868197607     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.065     Document Type: Article

References (50)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
2. Wagner V., Dullaart A., Bock A.-K., Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006, 24:1211-1217.
3. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
4. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011, 6:815-823.
5. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., Brown P.A., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:389-397.
6. Von Maltzahn G., Park J.-H., Lin K.Y., Singh N., Schwoppe C., Mesters R., et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater 2011, 10:545-552.
7. Chauhan V.P., Stylianopoulos T., Martin J.D., Popovic Z., Chen O., Kamoun W.S., et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 2012, 7:383-388.
8. Murphy E.A., Majeti B.K., Mukthavaram R., Acevedo L.M., Barnes L.A., Cheresh D.A. Targeted nanogels: a versatile platform for drug delivery to tumors. Mol Cancer Ther 2011, 10:972-982.
9. Xiao K., Luo J., Fowler W.L., Li Y., Lee J.S., Xing L., et al. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials 2009, 30:6006-6016.
10. Bae Y.H., Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 2011, 153:198-205.
11. Ruenraroengsak P., Cook J.M., Florence A.T. Nanosystem drug targeting: facing up to complex realities. J Control Release 2010, 141:265-276.
12. Siegwart D.J., Whitehead K.A., Nuhn L., Sahay G., Cheng H., Jiang S., et al. Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Nat Acad Sci U S A 2011, 108:12996-13001.
13. Kim J.Y., Kim S., Pinal R., Park K. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs. J Control Release 2011, 152:13-20.
14. Giacomelli C., Schmidt V., Aissou K., Borsali R. Block copolymer systems: from single chain to self-assembled nanostructures. Langmuir 2010, 26:15734-15744.
15. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., Kataoka K. Long-circulating poly(ethylene glycol)-poly(d, l-lactide) block copolymer micelles with modulated surface charge. J Control Release 2001, 77:27-38.
16. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res 1986, 46:6387-6392.
17. Savic R., Azzam T., Eisenberg A., Maysinger D. Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions: a fluorogenic-based approach. Langmuir 2006, 22:3570-3578.
18. Chen H., Kim S., He W., Wang H., Low P.S., Park K., et al. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo Forster resonance energy transfer imaging. Langmuir 2008, 24:5213-5217.
19. Letchford K., Burt H.M. Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol Pharm 2012, 9:248-260.
20. Mitragotri S., Lahann J. Physical approaches to biomaterial design. Nat Mater 2009, 8:15-23.
21. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
22. Jocelyn P.C. Biochemistry of the SH group 1972, Academic Press, London.
23. Sevier C.S., Kaiser C.A. Formation and transfer of disulphide bonds in living cells. Nat Rev Mol Cell Biol 2002, 3:836-847.
24. Cantin A.M., North S.L., Hubbard R.C., Crystal R.G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987, 63:152-157.
25. Smith C.V., Jones D.P., Guenthner T.M., Lash L.H., Lauterburg B.H. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol 1996, 140:1-12.
26. Russo A., DeGraff W., Friedman N., Mitchell J.B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 1986, 46:2845-2848.
27. Cook J.A., Pass H.I., Iype S.N., Friedman N., DeGraff W., Russo A., et al. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res 1991, 51:4287-4294.
28. Balendiran G.K., Dabur R., Fraser D. The role of glutathione in cancer. Cell Biochem Funct 2004, 22:343-352.
29. Chen H., Kim S., Li L., Wang S., Park K., Cheng J.-X. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging. Proc Nat Acad Sci U S A 2008, 105:6596-6601.
30. Matsumoto J., Nakada Y., Sakurai K., Nakamura T., Takahashi Y. Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro. Int J Pharm 1999, 185:93-101.
31. Ahmed F., Discher D.E. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. J Control Release 2004, 96:37-53.
32. Lee S.-Y., Lee S., Youn I.-C., Yi D.K., Lim Y.T., Chung B.H., et al. A near-infrared fluorescence-based optical thermosensor. Chemistry 2009, 15:6103-6106.
33. Choi K.Y., Yoon H.Y., Kim J.-H., Bae S.M., Park R.-W., Kang Y.M., et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 2011, 5:8591-8599.
34. Lovell J.F., Jin C.S., Huynh E., Jin H., Kim C., Rubinstein J.L., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011, 10:324-332.
35. Schlessinger J., Axelrod D., Koppel D., Webb W., Elson E. Lateral transport of a lipid probe and labeled proteins on a cell membrane. Science 1977, 195:307-309.
36. Li Y., Song Y., Zhao L., Gaidosh G., Laties A.M., Wen R. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc 2008, 3:1703-1708.
37. Axelrod D. Carbocyanine dye orientation in red cell membrane studied by microscopic fluorescence polarization. Biophys J 1979, 26:557-573.
38. Wooles W.R., Di Luzio N.R. Reticuloendothelial function and the immune response. Science 1963, 142:1078-1080.
39. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998, 339:900-905.
40. Andrew MacKay J., Chen M., McDaniel J.R., Liu W., Simnick A.J., Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater 2009, 8:993-999.
41. Yamada A., Taniguchi Y., Kawano K., Honda T., Hattori Y., Maitani Y. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res 2008, 14:8161-8168.
42. Taniguchi Y., Kawano K., Minowa T., Sugino T., Shimojo Y., Maitani Y. Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitor. Cancer Sci 2010, 101:2207-2213.
43. Ko J.Y., Park S., Lee H., Koo H., Kim M.S., Choi K., et al. pH-sensitive nanoflash for tumoral acidic pH imaging in live animals. Small 2010, 6:2539-2544.
44. Murakami M., Cabral H., Matsumoto Y., Wu S., Kano M.R., Yamori T., et al. Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting. Sci Transl Med 2011, 3:64ra2.
45. Werner M.E., Copp J.A., Karve S., Cummings N.D., Sukumar R., Li C., et al. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy. ACS Nano 2011, 5:8990-8998.
46. Koo A.N., Min K.H., Lee H.J., Lee S.-U., Kim K., Kwon I.C., et al. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials 2012, 33:1489-1499.
47. Li Y., Xiao K., Luo J., Xiao W., Lee J.S., Gonik A.M., et al. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials 2011, 32:6633-6645.
48. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60:1615-1626.
49. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006, 66:6732-6740.
50. Bartlett D.W., Su H., Hildebrandt I.J., Weber W.A., Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Nat Acad Sci U S A 2007, 104:15549-15554.